Deletions
The following codes will be deleted effective January 1, 2010:
A4365
Adhesive remover wipes, any type, per 50
A6200
Composite dressing, pad size 16 sq. in. or less, without adhesive border, each dressing
A6201
Composite dressing, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing
A6202
Composite dressing, pad size more than 48 sq. in., without adhesive border, each dressing
A6542
Gradient compression stocking, custom made
A6543
Gradient compression stocking, lymphedema
A9535
Injection, methylene blue, 1 ml
A9605
Samarium sm-153 lexidronamm, therapeutic, per 50 millicuries
C9245
Injection, romiplostim, 10 mcg
C9246
Injection, gadoxetate disodium, per ml
C9247
Iobenguane, I-123, diagnostic, per study dose, up to 10 millicuries
C9249
Injection, certolizumab pegol, 1 mg
C9251
Injection, C1 esterase inhibitor (human), 10 units
C9252
Injection, plerixafor, 1 mg
C9253
Injection, temozolomide, 1 mg
E1340
Repair or non-routine service for durable medical equipment requiring the skill of a technician, labor component, per 15 minutes
E2223
Manual wheelchair accessory, valve, any type, replacement only, each
E2393
Power wheelchair accessory, valve for pneumatic tire tube, any type, replacement only, each
E2399
Power wheelchair accessory, not otherwise classified interface, including all related electronics and any type mounting hardware
G0392
Transluminal balloon angioplasty, percutaneous; for maintenance of hemodialysis access, arteriovenous fistula or graft; arterial
G0393
Transluminal balloon angioplasty, percutaneous; for maintenance of hemodialysis access, arteriovenous fistula or graft; venous
G8503
Documentation that prophylactic antibiotic was given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)
G8504
Documentation of order for prophylactic antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)
G8505
Documentation that prophylactic antibiotic was not given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required), reason not specified
G8512
Pain severity quantified; pain present
G8513
ABI measured and documented
G8514
Clinician documented that patient was not an eligible candidate for ABI measurement measure
G8515
ABI measurement was not obtained
G8516
Patient screened for future falls risk; documentation of two or more falls in the past year or any fall with injury in the past year
G8517
Patient screened for future fall risk; documentation of no falls in the past year or only one fall without injury in the past year
G8521
Antiplatelet therapy received (ASA [81-325 mg/day] and/or clopidogrel [75 mg/day]) within 48 hours of the initiation of surgery and at discharge
G8522
Clinician documented that patient was not an eligible candidate for antiplatelet therapy
G8523
Antiplatelet therapy not received 48 hours prior to CEA and at discharge, reason not specified
G8527
Documentation of order for cefazolin or cefuroxime for antimicrobial prophylaxis
G8528
Clinician documented that patient was ineligible for prophylactic antibiotic selection measure
G8529
Order for cefazolin or cefuroxime for antimicrobial prophylaxis not documented, reason not specified
G8533
Participation by a physician or other clinician in systematic clinical database registry that includes consensus-endorsed quality measures
J0460
Injection, atropine sulfate, up to 0.3 mg
J0530
Injection, penicillin G benzathine and penicillin G procaine, up to 600,000 units
J0540
Injection, penicillin G benzathine and penicillin G procaine, up to 1,200,000 units
J0550
Injection, penicillin G benzathine and penicillin G procaine, up to 2,400,000 units
J0835
Injection, cosyntropin, per 0.25 mg
J1565
Injection, respiratory syncytial virus immune globulin, intravenous, 50 mg
J7322
Hyaluronan or derivative, synvisc, for intra-articular injection, per dose
J9170
Injection, docetaxel, 20 mg
L0210
Thoracic, rib belt
L1800
Knee orthosis, elastic with stays, prefabricated, includes fitting and adjustment
L1815
Knee orthosis, elastic or other elastic type material with condylar pad(s), prefabricated, includes fitting and adjustment
L1825
Knee orthosis, elastic knee cap, prefabricated, includes fitting and adjustment
L1901
Ankle orthosis, elastic, prefabricated, includes fitting and adjustment (e.g., neoprene, lycra)
L2770
Addition to lower extremity orthosis, any material – per bar or joint
L3651
Shoulder orthosis, single shoulder, elastic, prefabricated, includes fitting and adjustment (e.g., neoprene, lycra)
L3652
Shoulder orthosis, double shoulder, elastic, prefabricated, includes fitting and adjustment (e.g., neoprene, lycra)
L3700
Elbow orthosis, elastic with stays, prefabricated, includes fitting and adjustment
L3701
Elbow orthosis, elastic, prefabricated, includes fitting and adjustment (e.g., neoprene, lycra)
L3909
Wrist orthosis, elastic, prefabricated, includes fitting and adjustment (e.g., neoprene, lycra)
L3911
Wrist hand finger orthosis, elastic, prefabricated, includes fitting and adjustment (e.g., neoprene, lycra)
L6639
Upper extremity addition, heavy duty feature, any elbow
Q2023
Injection, factor VIII (antihemophilic factor, recombinant) (xyntha), per i.u.
Q2024
Injection, bevacizumab, 0.25 mg
Q4080
Iloprost, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, 20 micrograms
